|
TSLA
|
Consumer Cyclical |
Goldman Sachs |
Downgrade
|
Buy
→
Neutral
|
—
|
$1.4T
|
$64.86
|
+0.7%
|
-3.9%
|
+6.0%
|
-0.9%
|
+1.0%
|
+1.2%
|
|
TSLA
|
Consumer Cyclical |
Morgan Stanley |
Downgrade
|
Equal Weight
→
Underweight
|
—
|
$1.4T
|
$64.86
|
+0.7%
|
-3.9%
|
+6.0%
|
-0.9%
|
+1.0%
|
+1.2%
|
|
CAT
|
Industrials |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$409.2B
|
$121.55
|
+2.3%
|
+1.3%
|
+0.4%
|
+5.3%
|
-1.4%
|
-0.5%
|
|
MRK
|
Healthcare |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$286.5B
|
$73.76
|
+0.7%
|
-1.4%
|
-3.0%
|
+4.0%
|
-0.9%
|
-0.1%
|
|
AME
|
Industrials |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$52.0B
|
$88.09
|
+2.2%
|
-0.5%
|
+0.7%
|
+2.8%
|
-0.8%
|
-0.9%
|
|
ROP
|
Industrials |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$35.5B
|
$392.30
|
+2.3%
|
-0.6%
|
+1.1%
|
+1.2%
|
+0.9%
|
-0.0%
|
|
UAL
|
Industrials |
Credit Suisse |
Downgrade
|
Outperform
→
Neutral
|
—
|
$29.1B
|
$33.32
|
+12.6%
|
+19.0%
|
-1.7%
|
+3.1%
|
-2.4%
|
+0.2%
|
|
ESS
|
Real Estate |
Raymond James |
Downgrade
|
Market Perform
→
Underperform
|
—
|
$17.6B
|
$246.09
|
+1.2%
|
+1.5%
|
-2.0%
|
+2.8%
|
-3.4%
|
-0.1%
|